ORAMED PHARMACEUTICALS INC. Uncategorized Contracts & Agreements
37 Contracts & Agreements
- At The Market Offering Agreement, dated March 18, 2024, by and among the Company, Rodman & Renshaw LLC and StockBlock Securities LLC (Filed With SEC on March 18, 2024)
- Description of Securities (Filed With SEC on March 6, 2023)
- Engagement Letter, dated as of November 2, 2021, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on November 4, 2021)
- Stockholders Agreement, dated as of March 18, 2021, by and between Oramed Pharmaceuticals Inc., Akers Biosciences Inc., Premas Biotech PVT Ltd., Cutter Mill Capital LLC, and Run... (Filed With SEC on March 19, 2021)
- Description of Securities (Filed With SEC on November 24, 2020)
- Description of Securities (Filed With SEC on November 27, 2019)
- Engagement Letter, dated as of July 2, 2018, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on July 5, 2018)
- INDEMNIFICATIONAGREEMENT (Filed With SEC on January 11, 2017)
- AGREEMENTAND AMENDMENT NO. 5 (Filed With SEC on January 11, 2017)
- **Confidentialportions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securitiesand Exchange Commission (the... (Filed With SEC on November 25, 2016)
- OramedPharmaceuticals, Inc. | 2 Elza Street, Jerusalem, Israel 93706. | www.oramedpharma.com Phone:011 ###-###-#### | Fax: 011 972-2 ###-###-#### | Email: ***@*** (Filed With SEC on November 25, 2016)
- AGREEMENTAND AMENDMENT NO. 4 (Filed With SEC on November 25, 2016)
- AGREEMENT AND AMENDMENT NO. 4 (Filed With SEC on November 25, 2016)
- AGREEMENTAND AMENDMENT NO. 2 (Filed With SEC on November 25, 2015)
- AGREEMENTAND AMENDMENT NO. 3 (Filed With SEC on November 25, 2015)
- AGREEMENTAND AMENDMENT NO. 3 (Filed With SEC on November 25, 2015)
- 430 Park Avenue|New York, New York 10022 ###-###-####|www.hcwco.com Member: FINRA/SIPC (Filed With SEC on June 5, 2015)
- AGREEMENT AND AMENDMENT NO. 1 (Filed With SEC on November 14, 2014)
- AGREEMENT AND AMENDMENT NO. 1 (Filed With SEC on November 14, 2014)
- AGREEMENT AND AMENDMENT NO. 1 (Filed With SEC on November 14, 2014)
- AGREEMENT (Filed With SEC on January 14, 2014)
- Sincerely,/s/ Nadav KidronNadav Kidron, CEO (Filed With SEC on February 1, 2013)
- AMENDMENT NO. 1 TO OPTION OF ORAMED PHARMACEUTICALS INC. (Filed With SEC on February 1, 2013)
- TEN COM - as tenants in commonTEN ENT - as tenants by the entiretiesJT TEN -as joint tenants with right of survivorship and not as tenants in commonUNIF GIFT MIN ACT -... (Filed With SEC on February 1, 2013)
- **CONFIDENTIAL PORTIONS HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION (THE... (Filed With SEC on December 12, 2012)
- RECITALS: (Filed With SEC on December 12, 2012)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on December 12, 2012)
- Patent Transfer Agreement (Filed With SEC on March 25, 2011)
- PLAN OF CONVERSION OF ORAMED PHARMACEUTICALS INC., a Nevada corporation TO ORAMED PHARMACEUTICALS INC., a Delaware corporation (Filed With SEC on March 14, 2011)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 13, 2011)
- ACTIVE PHARMACEUTICALINGREDIENT MANUFACTURING AND CLINICALSUPPLY AGREEMENT (RECOMBINANTHUMAN INSULIN) (Filed With SEC on July 14, 2010)
- CLINICALTRIAL AGREEMENT (Filed With SEC on July 9, 2009)
- ORAMEDPHARMACEUTICALS, INC. INDEMNIFICATIONAGREEMENT (Filed With SEC on April 22, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on April 22, 2009)
- AGREEMENT (Filed With SEC on January 13, 2009)
- AGREEMENT (Filed With SEC on January 7, 2009)
- Form of Expense Agreement dated January 18, 2008 with Leonard Sank (Filed With SEC on February 1, 2008)
